VTVT - vTv Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $27.68. This is a potential upside of $0.71 (2.63%) from yesterday's end of day stock price of $26.97.

vTv Therapeutics's activity chart (see below) currently has 0 price targets and 2 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 461 days.

Most recent stock forecast was given by CARL BYRNES from NORTHLAND CAPITAL MARKETS on 17-Aug-2022. First documented stock forecast 17-Aug-2022.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$-9.5 (-82.61%)

1 years 8 months 9 days ago

1/1 (100%)

$0.71 (55.04%)

461

Show more analysts

What is VTVT (vTv Therapeutics) average time for price targets to be met?

On average it took 461 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on VTVT (vTv Therapeutics) with a proven track record?

CARL BYRNES

Which analyst has the most public recommendations on VTVT (vTv Therapeutics)?

Carl Byrnes works at NORTHLAND CAPITAL MARKETS and has 8 price targets and 5 ratings on VTVT

Which analyst is the currently most bullish on VTVT (vTv Therapeutics)?

Carl Byrnes with highest potential upside - $-9.5